IDS goes for experience with new CEO Patrik Dahlen
This article was originally published in Clinica
Executive Summary
A week after Ian Cookson stepped down as CEO of UK vitamin D testing specialist Immunodiagnostics Systems (IDS), the firm has named Dako and Perkin Elmer veteran Patrik Dahlen as its new leader. Mr Dahlen has been a member of IDS's board since December 2009; a spokesperson for the company told Clinica that his promotion to CEO was not part of a longer-term succession plan, but that Mr Dahlen "became the sensible choice" after Mr Cookson's resignation on 25 June "by mutual consent" after nearly two years in the post. At the time, the company said it was in discussions with a candidate with "substantial diagnostic and international industry experience".
You may also be interested in...
What are the hottest innovations from Israel?
Israel is well-known as a medtech hot-spot, with a focus on academic research and strong government support helping the country punch well above its weight when it comes to innovative devices.
EuroPCR: St Jude and Philips talk up rival intravascular imaging techs
St Jude Medical had a heavy focus on its intravascular imaging offering at this year’s EuroPCR meeting, presenting data supporting its optical coherence tomography (OCT) technology. OCT provides intravascular images to help assess culprit lesions, which can improve stent selection and deployment, according to St Jude.
EuroPCR: Medtronic's drug-coated balloon keeps rising
A big topic at this year’s EuroPCR, held in Paris on 19-22 May, was drug-coated balloons (DCBs). One of the leaders in the field, Medtronic, presented positive data from two studies of its IN.PACT Admiral balloon, which could support an expanded indication for the device.